Back to News
Market Impact: 0.15
Estrella Immunopharma Names Cynthia Pussinen CEO, Succeeding Cheng Liu
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Estrella Immunopharma appointed Cynthia Pussinen CEO and Board Chair, effective October 25, 2026. She succeeds Cheng Liu; the article text is truncated before stating Liu’s next role.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
ESLA0.10
More News
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Microsoft offers to buy out a quarter of its workforce
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Microsoft offers voluntary buyouts to 60,000 employees
- Anthropic's IPO puts power in the hands of founders, giving everyday shareholders little voice